2018-03-06T15:16:34
NEW DRUG APPROVED FOR HIV TREATMENT
Bictegravir (BIC) is an unboosted HIV integrase inhibitor with a high in vitro barrier to resistance. The U.S. FDA has now approved the combination of BIC with emtricitabine and tenofovir alafenamide in a single-pill formulation (BIC/FTC/TAF; Biktarvy)